![Cornelius S. Sobel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cornelius S. Sobel
Keine laufenden Positionen mehr
Profil
Dr. Cornelius S.
Sobel is Head-European Development & Regulatory Affairs at Dragonfly Sciences, Inc.
Dr. Sobel was previously employed as Chief Scientific Officer by Biopartners GmbH and Head-Production & Regulatory Affairs by Merck KGaA.
He received his undergraduate degree from The Johannes Gutenberg University of Mainz.
Ehemalige bekannte Positionen von Cornelius S. Sobel
Unternehmen | Position | Ende |
---|---|---|
Dragonfly Sciences, Inc.
![]() Dragonfly Sciences, Inc. BiotechnologyHealth Technology Dragonfly Sciences, Inc. develops biosimilar products of monoclonal antibodies and soluble receptors. The company was founded by Frank D. Lee in 2005 and is headquartered in Wellesley, MA. | General Counsel | - |
MERCK KGAA | General Counsel | - |
Biopartners GmbH
![]() Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Gründer | - |
Ausbildung von Cornelius S. Sobel
The Johannes Gutenberg University of Mainz | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MERCK KGAA | Health Technology |
Private Unternehmen | 2 |
---|---|
Biopartners GmbH
![]() Biopartners GmbH Pharmaceuticals: MajorHealth Technology Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland. | Health Technology |
Dragonfly Sciences, Inc.
![]() Dragonfly Sciences, Inc. BiotechnologyHealth Technology Dragonfly Sciences, Inc. develops biosimilar products of monoclonal antibodies and soluble receptors. The company was founded by Frank D. Lee in 2005 and is headquartered in Wellesley, MA. | Health Technology |